The organization is deploying the LumiSystem, which uses fluorescent dye and a small scope to illuminate cancerous tissue in the breast cavity during lumpectomy surgery.

In a new report, the AHA said strains from President Trump’s tariffs and struggles with Medicare Advantage plans are creating “financial headwinds” that could shake the economic stability of hospitals nationwide. 

The newly approved device can be worn for up to a week at a time, with no daily maintenance required, and includes advanced AI algorithms that minimize the risk of false alarms or inappropriate shocks.

The company cited declining enrollment as the reason for exiting the exchanges, including from patients seeking Medicare options. 

New TAVR data on SAPT vs. DAPT and prosthesis-patient mismatch among women were some of the many highlights of the conference's opening day.

Philippe Genereux, MD, principal investigator of EARLY TAVR, presented new data at ACC.25 showing intervening early on crossover patients with asymptomatic severe aortic stenosis led to better outcomes and a reduced stroke rate. 

The FDA has approved the balloon-expandable Sapien 3 TAVR platform from Edwards Lifesciences for treating asymptomatic severe aortic stenosis. This is the first time the agency has approved any TAVR technology to be used in asymptomatic patients. 

“Epic Campaigns offers an easy-to-use, all-in-one platform to reach patients for preventive screening," researchers detailed Tuesday in JACR. 

Lawsuits filed against the Alabama Medical Cannabis Commission claim the agency has failed to develop the necessary database to license and certify providers in the state, effectively making medical cannabis inaccessible. The law allowing for medical marijuana use passed in 2021. 

Patrick Conway, MD, has been with Optum since 2020, previously serving in federal healthcare agencies under George W. Bush and Barack Obama. He takes over as the company’s new CEO, effective May 6.